Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

View:
Post by zakmirza on Aug 06, 2013 2:18pm

HALTED!

Now what?
Comment by Nohandledzep on Aug 06, 2013 2:39pm
well that should explain the wall at 35 cents!!!!!!! An equity offering on a "best efforts" basis...Only at Bioniche. I hope GW has a fair shot at the new paper or its another 15 mil shares into friendly hads...Bring on the BEATDOWN! Clowns!
Comment by Nohandledzep on Aug 06, 2013 2:50pm
Hmmm...I thought I had heard recently that Bioniche had no intention of doing a placement at these levels as it would be too penal to shareholders and that they were looking for alternative sources of cash, like a Urocidin partnership that had upfront money included? Is it about the 5 mil or the 15 million votes??? Is this the board's interpretation of looking out for shareholders ...more  
Comment by Pogo3 on Aug 06, 2013 2:48pm
Graeme is, has been, and will continue to place the company into a difficult financial position where we the shareholders will have no other alternative than to accept his position of chasing the approval of Urocidin to the point where we may lose everything. What I read in the PR is that everything that is making profits or has the potential to make money in the near ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities